Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
TransMedics Group
ISIN US89377M1099
|WKN A2PH5P
Market cap (in EUR)
4,030 m
Country
United States
Sector
Healthcare
Dividend yield
0.00%
Overview
Description
TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA.
Healthcare Healthcare Equipment Other Medical Devices United States
Financials
Key metrics
| Market capitalisation, EUR | 4,030 m |
| EPS, EUR | 2.24 |
| P/B ratio | 13.2 |
| P/E ratio | 55.6 |
| Dividend yield | 0.00% |
Income statement (2024)
| Revenue, EUR | 408 m |
| Net income, EUR | 33 m |
| Profit margin | 8.03% |
What ETF is TransMedics Group in?
There are 31 ETFs which contain TransMedics Group. All of these ETFs are listed in the table below. The ETF with the largest weighting of TransMedics Group is the VanEck Medical Robotics and Bionic Engineering UCITS ETF A.
Latest articles
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.